Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-06-26

Clinical Trial Update: Detection and Prevention of Anthracycline-Related Cardiac Toxicity With Concurrent Simvastatin [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated detection and prevention of anthracycline-related cardiac toxicity with concurrent simvastatin in breast cancer patients; the study wa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Breast Cancer, Stage I Breast Cancer | Phase 2 | Status: TERMINATED | Results posted: 2019-06-26